163 related articles for article (PubMed ID: 29251177)
1. Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.
Lomert E; Turoverova L; Kriger D; Aksenov ND; Nikotina AD; Petukhov A; Mittenberg AG; Panyushev NV; Khotin M; Volkov K; Barlev NA; Tentler D
Cell Cycle; 2018; 17(5):616-626. PubMed ID: 29251177
[TBL] [Abstract][Full Text] [Related]
2. Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB.
Aksenova V; Turoverova L; Khotin M; Magnusson KE; Tulchinsky E; Melino G; Pinaev GP; Barlev N; Tentler D
Oncotarget; 2013 Feb; 4(2):362-72. PubMed ID: 23482348
[TBL] [Abstract][Full Text] [Related]
3. [alpha-Actinin-4 and p65/RelA subunit of NF-kappaB transcription factor are co-localized and migrate together into the nucleus in EGF-stimulated A431 cell].
Babakov VN; Bobkov DE; Petukhova OA; Turoverova LV; Kropacheva IV; Podol'skaia EP; Pinaev GP
Tsitologiia; 2004; 46(12):1064-72. PubMed ID: 15747836
[TBL] [Abstract][Full Text] [Related]
4. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
[TBL] [Abstract][Full Text] [Related]
5. [Novel splicing isoform of actin-binding protein alpha-actinin 4 in epidermoid carcinoma cells A431].
Aksenova VIu; Khotin MG; Turoverova LV; Iudintseva NM; Magnusson KÉ; Pinaev GP; Tentler DG
Tsitologiia; 2012; 54(1):25-32. PubMed ID: 22567897
[TBL] [Abstract][Full Text] [Related]
6. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
7. Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer.
Wang MC; Chang YH; Wu CC; Tyan YC; Chang HC; Goan YG; Lai WW; Cheng PN; Liao PC
J Thorac Oncol; 2015 Feb; 10(2):286-301. PubMed ID: 25299231
[TBL] [Abstract][Full Text] [Related]
8. EGF-induced dynamics of NF-κB and F-actin in A431 cells spread on fibronectin.
Bolshakova A; Magnusson KE; Pinaev G; Petukhova O
Histochem Cell Biol; 2015 Sep; 144(3):223-35. PubMed ID: 25990946
[TBL] [Abstract][Full Text] [Related]
9. RelA/NF-kappaB transcription factor associates with alpha-actinin-4.
Babakov VN; Petukhova OA; Turoverova LV; Kropacheva IV; Tentler DG; Bolshakova AV; Podolskaya EP; Magnusson KE; Pinaev GP
Exp Cell Res; 2008 Mar; 314(5):1030-8. PubMed ID: 18215660
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer.
Chen PH; Chang H; Chang JT; Lin P
Oncogene; 2012 May; 31(20):2555-65. PubMed ID: 21996739
[TBL] [Abstract][Full Text] [Related]
11. Rad GTPase inhibits the NFκB pathway through interacting with RelA/p65 to impede its DNA binding and target gene transactivation.
Hsiao BY; Chang TK; Wu IT; Chen MY
Cell Signal; 2014 Jul; 26(7):1437-44. PubMed ID: 24632303
[TBL] [Abstract][Full Text] [Related]
12. CARMA3 regulates the invasion, migration, and apoptosis of non-small cell lung cancer cells by activating NF-кB and suppressing the P38 MAPK signaling pathway.
Xia ZX; Li ZX; Zhang M; Sun LM; Zhang QF; Qiu XS
Exp Mol Pathol; 2016 Apr; 100(2):353-60. PubMed ID: 26526492
[TBL] [Abstract][Full Text] [Related]
13. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration.
Msaki A; Sánchez AM; Koh LF; Barré B; Rocha S; Perkins ND; Johnson RF
Mol Biol Cell; 2011 Sep; 22(17):3032-40. PubMed ID: 21737676
[TBL] [Abstract][Full Text] [Related]
14. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
16. The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells.
Khurana S; Chakraborty S; Cheng X; Su YT; Kao HY
J Biol Chem; 2011 Jan; 286(3):1850-9. PubMed ID: 21078666
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
19. ACTN4 regulates the stability of RIPK1 in melanoma.
Zhang YY; Tabataba H; Liu XY; Wang JY; Yan XG; Farrelly M; Jiang CC; Guo ST; Liu T; Kao HY; Thorne RF; Zhang XD; Jin L
Oncogene; 2018 Jul; 37(29):4033-4045. PubMed ID: 29706658
[TBL] [Abstract][Full Text] [Related]
20. N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression.
Xu H; Jiang B; Meng L; Ren T; Zeng Y; Wu J; Qu L; Shou C
Carcinogenesis; 2012 Jun; 33(6):1193-202. PubMed ID: 22496479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
